Xuemei Wang Selected Research

Breast Neoplasms (Breast Cancer)

1/2024	Gold nanomaterials: important vectors in biosensing of breast cancer biomarkers.
1/2023	Endogenous miRNA and K+ Co-Activated Dynamic Assembly of DNA Coacervates for Intracellular miRNA Imaging and Mitochondrial Intervention.
7/2022	Ultra-Small and Metabolizable Near-Infrared Au/Gd Nanoclusters for Targeted FL/MRI Imaging and Cancer Theranostics.
3/2022	Impact of body mass index, weight gain, and metabolic disorders on survival and prognosis in patients with breast cancer who underwent chemotherapy.
10/2021	Aptamer Embedded Arch-Cruciform DNA Assemblies on 2-D VS2 Scaffolds for Sensitive Detection of Breast Cancer Cells.
1/2019	Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421.
1/2015	Clinical Implications of TβRII Expression in Breast Cancer.
4/2014	Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance.
3/2014	Nestin: predicting specific survival factors for breast cancer.
10/2013	Steroid receptor RNA activator protein (SRAP) expression as a prognostic factor in ER+ human breast tumors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xuemei Wang Research Topics

Disease

216	Neoplasms (Cancer) 04/2024 - 01/2003
38	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 01/2003
31	Leukemia 01/2021 - 08/2006
29	Neoplasm Metastasis (Metastasis) 12/2023 - 07/2002
28	Adenocarcinoma 03/2024 - 01/2010
21	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 08/2004
20	Inflammation (Inflammations) 03/2024 - 01/2016
17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 04/2003
16	Breast Neoplasms (Breast Cancer) 01/2024 - 07/2006
16	Parkinson Disease (Parkinson's Disease) 01/2024 - 07/2015
14	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2007
14	Infections 03/2024 - 08/2011
13	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2011
13	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 08/2002
10	Body Weight (Weight, Body) 02/2024 - 12/2010
10	Lung Neoplasms (Lung Cancer) 05/2023 - 02/2011
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2012
10	Hypoxia (Hypoxemia) 03/2022 - 01/2008
10	Ischemic Stroke 01/2022 - 02/2014
10	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2002
9	Carcinoma (Carcinomatosis) 02/2022 - 07/2002
8	Colitis 03/2024 - 02/2017
8	Non-alcoholic Fatty Liver Disease 02/2024 - 02/2015
8	Hypertension (High Blood Pressure) 11/2023 - 03/2015
8	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 08/2004
8	Lymphatic Metastasis 01/2022 - 06/2006
7	Wounds and Injuries (Trauma) 02/2024 - 09/2009
6	Ulcerative Colitis 03/2024 - 12/2023
6	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2008
6	Stroke (Strokes) 01/2022 - 02/2014
6	Liver Neoplasms (Liver Cancer) 04/2020 - 09/2007
6	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 12/2010
5	Fibrosis (Cirrhosis) 05/2024 - 09/2007
5	Obesity 04/2024 - 10/2005
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 02/2010
5	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2018
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2016
5	Neutropenia 01/2021 - 09/2008
5	Esophageal Neoplasms (Esophageal Cancer) 08/2019 - 02/2009

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 05/2024 - 06/2002
33	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2004
29	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2015 - 08/2006
23	GoldIBA 02/2024 - 03/2007
13	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 05/2008
12	fludarabineIBA 11/2022 - 08/2004
10	CytokinesIBA 04/2024 - 09/2008
9	RNA (Ribonucleic Acid)IBA 12/2023 - 04/2005
9	Messenger RNA (mRNA)IBA 05/2023 - 09/2008
8	EnzymesIBA 02/2024 - 04/2014
8	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 03/2015
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 01/2002
8	AndrogensIBA 12/2023 - 06/2004
8	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 02/2007
8	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022 - 12/2008
8	MicroRNAs (MicroRNA)IBA 08/2022 - 04/2010
7	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 03/2011
7	Therapeutic UsesIBA 01/2024 - 10/2017
7	Hemoglobins (Hemoglobin)IBA 09/2023 - 08/2002
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 12/2006
7	Tyrosine Kinase InhibitorsIBA 01/2022 - 06/2011
7	Rituximab (Mabthera)FDA Link 12/2021 - 04/2003
7	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 07/2002
7	Prostate-Specific Antigen (Semenogelase)IBA 01/2021 - 07/2002
7	Caspase 3 (Caspase-3)IBA 10/2020 - 01/2009
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 02/2014
6	AntigensIBA 04/2024 - 06/2011
6	IonsIBA 02/2024 - 04/2016
6	MetalsIBA 02/2024 - 02/2015
6	LigandsIBA 01/2024 - 09/2008
6	Levodopa (L Dopa)FDA LinkGeneric 01/2024 - 01/2020
6	Peptides (Polypeptides)IBA 05/2022 - 01/2003
6	SolutionsIBA 01/2021 - 01/2013
6	ferric oxide (iron oxide)IBA 01/2020 - 01/2011
6	Antihypertensive Agents (Antihypertensives)IBA 04/2018 - 02/2014
5	Monoclonal AntibodiesIBA 10/2023 - 04/2003
5	SynucleinsIBA 08/2023 - 07/2015
5	ibrutinibIBA 01/2023 - 02/2016
5	Core Binding Factors (Core-Binding Factor)IBA 11/2022 - 12/2008
5	Neuroprotective AgentsIBA 01/2022 - 09/2011
5	BilirubinIBA 01/2022 - 06/2008
5	Decitabine FDA Link 01/2022 - 04/2009
5	AcidsIBA 01/2022 - 09/2008
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 08/2011
5	Small Interfering RNA (siRNA)IBA 10/2021 - 01/2008
5	ZincIBA 02/2020 - 07/2016

Therapy/Procedure

144	Therapeutics 04/2024 - 01/2002
45	Drug Therapy (Chemotherapy) 03/2024 - 06/2004
15	Precision Medicine 02/2024 - 07/2015
14	Prostatectomy (Retropubic Prostatectomy) 10/2020 - 04/2004
8	Gastrectomy 09/2023 - 09/2017
8	Aftercare (After-Treatment) 08/2022 - 12/2010
7	Photochemotherapy (Photodynamic Therapy) 02/2024 - 02/2012
7	Immunotherapy 01/2024 - 09/2008
7	Neoadjuvant Therapy 01/2023 - 01/2012
7	Radiotherapy 11/2022 - 08/2003
7	Lasers (Laser) 07/2022 - 04/2005
7	Castration 11/2021 - 03/2016
6	Electrodes (Electrode) 08/2022 - 11/2010
5	Nephrectomy 12/2021 - 09/2009
5	Hyperthermic Intraperitoneal Chemotherapy 01/2021 - 01/2010